Cunlin Wang

1.2k total citations
25 papers, 839 citations indexed

About

Cunlin Wang is a scholar working on Infectious Diseases, Oncology and Hematology. According to data from OpenAlex, Cunlin Wang has authored 25 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Cunlin Wang's work include HIV/AIDS Research and Interventions (5 papers), HIV Research and Treatment (4 papers) and HIV, Drug Use, Sexual Risk (3 papers). Cunlin Wang is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), HIV Research and Treatment (4 papers) and HIV, Drug Use, Sexual Risk (3 papers). Cunlin Wang collaborates with scholars based in United States, China and Australia. Cunlin Wang's co-authors include Sara B. Fein, Katherine R. Shealy, Judith Labiner‐Wolfe, David Vlahov, Joseph Bareta, Noya Galai, Thomas P. Gross, Kenrad E. Nelson, Federica Pisa and Sengwee Toh and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Cunlin Wang

24 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cunlin Wang United States 15 324 145 117 115 111 25 839
Taner Çamsarı Türkiye 18 147 0.5× 115 0.8× 67 0.6× 40 0.3× 74 0.7× 73 1.1k
Anthony D. Sung United States 19 122 0.4× 429 3.0× 124 1.1× 92 0.8× 88 0.8× 93 1.1k
Ronen Arnon United States 24 412 1.3× 75 0.5× 80 0.7× 118 1.0× 102 0.9× 86 1.8k
Randall S. Krakauer United States 23 226 0.7× 103 0.7× 150 1.3× 37 0.3× 38 0.3× 54 1.6k
Borja M. Fernández‐Félix Spain 11 83 0.3× 162 1.1× 56 0.5× 89 0.8× 28 0.3× 39 593
Sing Leung Lui China 26 213 0.7× 50 0.3× 87 0.7× 20 0.2× 113 1.0× 67 1.4k
A N Phillips United Kingdom 13 352 1.1× 104 0.7× 216 1.8× 56 0.5× 143 1.3× 14 1.2k
Amanda Ricciuto Canada 17 1.3k 4.0× 71 0.5× 145 1.2× 140 1.2× 115 1.0× 44 2.4k
Jean‐Pierre Wauters Switzerland 16 213 0.7× 62 0.4× 136 1.2× 42 0.4× 111 1.0× 45 1.0k
Tamir Miloh United States 26 485 1.5× 67 0.5× 119 1.0× 107 0.9× 70 0.6× 91 1.9k

Countries citing papers authored by Cunlin Wang

Since Specialization
Citations

This map shows the geographic impact of Cunlin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunlin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunlin Wang more than expected).

Fields of papers citing papers by Cunlin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cunlin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunlin Wang. The network helps show where Cunlin Wang may publish in the future.

Co-authorship network of co-authors of Cunlin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cunlin Wang. A scholar is included among the top collaborators of Cunlin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cunlin Wang. Cunlin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qiu, Haibo, Zhiwei Zhou, Ye Zhou, et al.. (2023). Antitumor activity of olverembatinib (HQP1351) in patients (pts) with tyrosine kinase inhibitor (TKI)–resistant succinate dehydrogenase (SDH)–deficient gastrointestinal stromal tumor (GIST).. Journal of Clinical Oncology. 41(16_suppl). 11540–11540. 3 indexed citations
3.
4.
Qin, Angel, Gregory P. Kalemkerian, Jyoti D. Patel, et al.. (2021). Trial in progress: A multicenter phase Ib/II study of pelcitoclax (APG-1252) in combination with paclitaxel in patients with relapsed/refractory small-cell lung cancer (R/R SCLC).. Journal of Clinical Oncology. 39(15_suppl). TPS8589–TPS8589. 4 indexed citations
5.
Wang, Cunlin, et al.. (2020). Use of real‐world evidence in regulatory decisions for rare diseases in the United States—Current status and future directions. Pharmacoepidemiology and Drug Safety. 29(10). 1213–1218. 72 indexed citations
6.
Pemmaraju, Naveen, Boyd Mudenda, Cunlin Wang, et al.. (2020). Trial in Progress: Phase Ib/II Study of Bcl-2/Bcl-Xl Inhibitor Pelcitoclax (APG-1252) in Patients with Myelofibrosis (MF) That Progressed after Initial Therapy. Blood. 136(Supplement 1). 15–16. 4 indexed citations
7.
8.
9.
Wang, Cunlin, David J. Graham, Robert C. Kane, et al.. (2015). Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products. JAMA. 314(19). 2062–2062. 151 indexed citations
10.
Qi, Youlin, Yuan‐Ting Zhang, Sara B. Fein, Cunlin Wang, & Nilsa Loyo‐Berríos. (2014). Independent Study Module for Lactation Consultants. Journal of Human Lactation. 30(1). 110–112.
11.
Qi, Youlin, Yuan‐Ting Zhang, Sara B. Fein, Cunlin Wang, & Nilsa Loyo‐Berríos. (2013). Maternal and Breast Pump Factors Associated with Breast Pump Problems and Injuries. Journal of Human Lactation. 30(1). 62–72. 32 indexed citations
12.
Inacio, Maria C., Christopher F. Ake, Elizabeth W. Paxton, et al.. (2013). Sex and Risk of Hip Implant Failure. JAMA Internal Medicine. 173(6). 435–435. 56 indexed citations
13.
Namba, Robert S., Maria C. Inacio, Elizabeth W. Paxton, et al.. (2012). Risk of Revision for Fixed Versus Mobile-Bearing Primary Total Knee Replacements. Journal of Bone and Joint Surgery. 94(21). 1929–1935. 34 indexed citations
14.
Wang, Cunlin, et al.. (2010). Emergency Department Visits for Medical Device-Associated Adverse Events Among Children. PEDIATRICS. 126(2). 247–259. 22 indexed citations
15.
Vlahov, David, Cunlin Wang, Danielle C. Ompad, et al.. (2008). Mortality Risk Among Recent-Onset Injection Drug Users in Five U.S. Cities. Substance Use & Misuse. 43(3-4). 413–428. 49 indexed citations
16.
Dalal, Darshan, et al.. (2006). Incidence of Atherosclerotic Cardiovascular Disease Among HIV Patients Receiving Dialysis. American Journal of Kidney Diseases. 47(5). 848–855. 5 indexed citations
17.
Wang, Cunlin, Saba W. Masho, & Daniel E. Nixon. (2006). When to start antiretroviral therapy. Current HIV/AIDS Reports. 3(2). 66–73. 3 indexed citations
18.
Wang, Cunlin, David Vlahov, Noya Galai, et al.. (2005). The effect of HIV infection on overdose mortality. AIDS. 19(9). 935–942. 42 indexed citations
19.
Wang, Cunlin, David Vlahov, Noya Galai, et al.. (2004). Mortality in HIV‐Seropositive versus ‐Seronegative Persons in the Era of Highly Active Antiretroviral Therapy: Implications for When to Initiate Therapy. The Journal of Infectious Diseases. 190(6). 1046–1054. 65 indexed citations
20.
Galai, Noya, David Vlahov, Joseph Bareta, et al.. (2004). Prognostic Factors for Survival Differ According to CD4+ Cell Count Among HIV-Infected Injection Drug Users. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(1). 74–81. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taner Çamsarı Breakdown of academic impact, for papers by Anthony D. Sung Breakdown of academic impact, for papers by Ronen Arnon Breakdown of academic impact, for papers by Randall S. Krakauer Breakdown of academic impact, for papers by Borja M. Fernández‐Félix Breakdown of academic impact, for papers by Sing Leung Lui Breakdown of academic impact, for papers by A N Phillips Breakdown of academic impact, for papers by Amanda Ricciuto Breakdown of academic impact, for papers by Jean‐Pierre Wauters Breakdown of academic impact, for papers by Tamir Miloh
Rankless by CCL
2026